Managing Insulin Pump Therapy During Fasting
Patients on CSII should continue their programmed basal rates during fasting periods while monitoring glucose hourly, with basal rates adjusted based on 24-hour fasting tests that reveal circadian insulin needs, particularly elevated requirements during the dawn period (01:00-07:00 am). 1
Basal Rate Management During Fasting
The basal insulin infusion should remain active during fasting, as these rates are specifically designed to maintain euglycemia without food intake. Research demonstrates that properly programmed basal rates maintain plasma glucose at 6.6 mmol/L (approximately 119 mg/dL) during 24-hour fasting periods, with 53% of time spent in the strict target range of 4.4-7.2 mmol/L (79-130 mg/dL) 1.
Circadian Basal Rate Patterns
Your basal rates should reflect physiologic insulin needs that vary throughout the day:
- Dawn period (01:00-07:00 am): Basal rates peak at approximately 1.07 IU/h, representing a 19% increase over the 24-hour average of 0.90 IU/h 1
- Dusk period (04:00-07:00 pm): Rates increase modestly to 0.95 IU/h 1
- These variations are physiologically justified—plasma glucose runs 0.5 mmol/L higher during dawn hours, and hypoglycemia risk is significantly lower during this period 1
Glucose Monitoring Protocol
Monitor capillary blood glucose hourly during fasting periods 2. This frequency is critical because:
- It allows rapid detection of hypo- or hyperglycemia
- The subcutaneous insulin depot from CSII can cause delayed effects
- Individual basal rate adequacy can only be assessed with frequent monitoring
When to Intervene
- Hypoglycemia (glucose <4 mmol/L or 72 mg/dL): Treat according to standard hypoglycemia protocol; if recurrent, disconnect pump and consider alternative insulin delivery 2
- Uncontrolled hyperglycemia: Change to intravenous insulin infusion 2
Optimizing Basal Rates Through Fasting Tests
The 24-hour fasting basal rate test remains the gold standard for customizing hour-by-hour insulin delivery 1. This should ideally be performed:
- In a supervised setting (inpatient or closely monitored outpatient)
- With hourly glucose measurements
- To identify specific time periods requiring basal rate adjustments
A critical pitfall: Do not rely solely on morning fasting glucose to assess basal adequacy 3. Late evening meals can artificially elevate morning glucose, leading to excessive basal insulin dosing and subsequent hypoglycemia during true fasting states.
Perioperative Fasting Considerations
For minor procedures where the patient remains conscious and competent:
- Continue CSII with hourly glucose monitoring 2
- Position the infusion site away from the surgical field
- Re-site the infusion set the day before surgery 2
For major surgery or procedures requiring nil-by-mouth status beyond one meal, discontinue the pump and transition to intravenous insulin 2. The programmed basal rate provides an excellent starting point for IV insulin dosing—use equivalent hourly rates initially, then titrate based on hourly glucose monitoring.
Critical Safety Point
When transitioning from pump to IV insulin, start the IV infusion at least 30 minutes before disconnecting the pump to prevent rapid hyperglycemia and ketosis 2. The subcutaneous insulin depot depletes quickly, and patients with type 1 diabetes have no endogenous insulin production.
Special Populations
For insulin-resistant patients requiring high doses, the pump offers advantages through precise delivery of small incremental adjustments 4. However, patients requiring very large total daily doses may benefit from hybrid approaches, such as administering half the basal insulin via subcutaneous injection and using the pump for the remainder with automated insulin delivery 5.